MedPath

Bipolar Versus Mono-polar Needlescopic En Bloc TUR-BT

Not Applicable
Conditions
Bladder Neoplasm
Bladder Cancer
Registration Number
NCT04839029
Lead Sponsor
Benha University
Brief Summary

Non-muscle invasive bladder cancers (NMIBC) compose about 80% of bladder tumors. the stranded treatment of these tumors is TURBT.

en bloc resection of NMIBC yields better mascularis propria with better oncological outcomes

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
200
Inclusion Criteria
  • confirmed primary NMIBC (Ta, Tis, T1)
  • Age > 18 years
Exclusion Criteria
  • MIBC
  • anterior located mass ( difficult or non visualized)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Quality of tumor Resectionimmediatly post operative

presence of detrusor muscle

adequacy of tumor Resection2 to 6 weeks postoprative

Presence of residual tumor at the bed of previously resected NMIBC

Secondary Outcome Measures
NameTimeMethod
Complicationswithin 30 days post-operative

Modified Clavien-Dindo classification scale

Trial Locations

Locations (1)

Banha university hospital

🇪🇬

Banhā, Qalubia, Egypt

Banha university hospital
🇪🇬Banhā, Qalubia, Egypt

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.